“…However, the amount of CECs detectable in peripheral blood has been recently proposed as a reliable marker of endothelial damage in different vascular diseases, such as acute coronary syndrome (also after coronary angioplasty), sickle cell anemia, thrombotic thrombocytopenic purpura, rickettsial and cytomegalovirus infections, Behçet's disease, SLE, and small-vessel vasculitides (7)(8)(9)(10)(11)(12)(13)(14)(15). Thus, the detection of CECs in patients with SSc is certainly not surprising, because results of several histologic studies of dermal microvas- culature in this disease, which demonstrated disruption of the normal architecture of the endothelium with loss of intercellular junctions and progressive death of endothelial cells (3)(4)(5)(6), have suggested that endothelium may play a key role in the pathologic process of SSc.…”